Exhaled carbon monoxide levels in infants and toddlers with episodic asthma

Yoichiro Ohara1, Takahiro Ohara2, Koichi Hashimoto3

  • 1Ohara Children's Clinic.

Insights

Exhaled carbon monoxide (eCO) levels can effectively evaluate asthma activity in infants and toddlers. This novel method aids in diagnosing asthma and assessing treatment response in young children.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Biomarker Research

Background:

  • Limited lung function tests exist for evaluating bronchial asthma in infants and toddlers.
  • Exhaled carbon monoxide (eCO) is a potential non-invasive biomarker for airway inflammation.

Purpose of the Study:

  • To assess the applicability of exhaled carbon monoxide (eCO) measurements in evaluating stable asthma and acute asthma attacks in infants and toddlers.
  • To test the hypothesis that eCO levels correlate with asthma status in young children.

Main Methods:

  • A novel one-way valve breath sampling bag was developed for collecting exhaled air from infants and toddlers.
  • A total of 483 participants were studied: 355 with asthma (182 with attacks, 173 asymptomatic), 119 with upper respiratory infection (URI), and 9 healthy controls.

Main Results:

  • eCO levels were significantly higher in infants and toddlers during asthma attacks compared to asymptomatic asthma, URI, and healthy controls.
  • eCO levels decreased significantly after therapy in children with asthma.
  • eCO cut-off values demonstrated varying sensitivity and specificity in discriminating asthma attacks and diagnosing asthma in this age group.

Conclusions:

  • Measurement of exhaled carbon monoxide (eCO) using a novel method is applicable for evaluating asthmatic activity in infants and toddlers.
  • This method shows potential for assessing treatment responsiveness and aiding in the diagnosis of asthma in this population.
Abstract

Related Concept Videos

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.1K
Assessment of Diffusion and Perfusion01:17

Assessment of Diffusion and Perfusion

Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
1.4K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.9K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
619